<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Endocrinol</journal-id><journal-id journal-id-type="publisher-id">JOE</journal-id><journal-title-group><journal-title>The Journal of Endocrinology</journal-title></journal-title-group><issn pub-type="ppub">0022-0795</issn><issn pub-type="epub">1479-6805</issn><publisher><publisher-name>BioScientifica</publisher-name><publisher-loc>Bristol</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">JOE090003</article-id><article-id pub-id-type="doi">10.1677/JOE-09-0003</article-id><article-categories><subj-group subj-group-type="heading"><subject>Regular papers</subject></subj-group></article-categories><title-group><article-title>Dysregulation of glucocorticoid metabolism in murine obesity: comparable effects of leptin resistance and deficiency</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Livingstone</surname><given-names>Dawn E W</given-names></name></contrib><contrib contrib-type="author"><name><surname>Grassick</surname><given-names>Sarah L</given-names></name></contrib><contrib contrib-type="author"><name><surname>Currie</surname><given-names>Gillian L</given-names></name></contrib><contrib contrib-type="author"><name><surname>Walker</surname><given-names>Brian R</given-names></name></contrib><contrib contrib-type="author"><name><surname>Andrew</surname><given-names>Ruth</given-names></name><xref ref-type="corresp" rid="cor1"/></contrib></contrib-group><aff id="aff1"><label>1</label><institution>Endocrinology Unit</institution><institution>Queen's Medical Research Institute, Centre for Cardiovascular Science, University of Edinburgh</institution><addr-line>47, Little France Crescent, Edinburgh EH16 4TJ</addr-line><country>UK</country></aff><author-notes><corresp id="cor1">(Correspondence should be addressed to R Andrew; Email: <email>ruth.andrew@ed.ac.uk</email>)</corresp></author-notes><pub-date pub-type="ppub"><month>5</month><year>2009</year></pub-date><pub-date pub-type="epreprint"><day>16</day><month>2</month><year>2009</year></pub-date><volume>201</volume><issue>2</issue><fpage>211</fpage><lpage>218</lpage><history><date date-type="rev-recd"><day>9</day><month>2</month><year>2009</year></date><date date-type="accepted"><day>13</day><month>2</month><year>2009</year></date></history><permissions><copyright-statement>&#x000a9; 2009 Society for Endocrinology</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" xlink:href="http://www.endocrinology.org/journals/reuselicence/"><license-p>This is an Open Access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://www.endocrinology.org/journals/reuselicence/">Society for Endocrinology's Re-use Licence</ext-link> which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>In obese humans, metabolism of glucocorticoids by 11&#x003b2;-hydroxysteroid dehydrogenase type 1 (11&#x003b2;-HSD1) and A-ring reduction (by 5&#x003b1;- and 5&#x003b2;-reductases) is dysregulated in a tissue specific manner. These changes have been recapitulated in leptin resistant obese Zucker rats but were not observed in high-fat fed Wistar rats. Recent data from mouse models suggest that such discrepancies may reflect differences in leptin signalling. We therefore compared glucocorticoid metabolism in murine models of leptin deficiency and resistance. Male <italic>ob/ob</italic> and <italic>db/db</italic> mice and their respective littermate controls (<italic>n</italic>=10&#x02013;12/group) were studied at the age of 12 weeks. Enzyme activities and mRNA expression were quantified in snap-frozen tissues. The patterns of altered pathways of steroid metabolism in obesity were similar in <italic>ob/ob</italic> and <italic>db/db</italic> mice. In liver, 5&#x003b2;-reductase activity and mRNA were increased and 11&#x003b2;-HSD1 decreased in obese mice, whereas 5&#x003b1;-reductase 1 (5&#x003b1;R1) mRNA was not altered. In visceral adipose depots, 5&#x003b2;-reductase was not expressed, 11&#x003b2;-HSD1 activity was increased and 5&#x003b1;R1 mRNA was not altered in obesity. By contrast, in subcutaneous adipose tissue 11&#x003b2;-HSD1 and 5&#x003b1;R1 mRNA were decreased. Systematic differences were not found between <italic>ob/ob</italic> and <italic>db/db</italic> murine models of obesity, suggesting that variations in leptin signalling through the short splice variant of the Ob receptor do not contribute to dysregulation of glucocorticoid metabolism.</p></abstract><funding-group><award-group><funding-source id="CS200">Wellcome Trust</funding-source><award-id rid="CS200">060707 and VS/06/UED/A8</award-id></award-group></funding-group></article-meta></front><body><sec><title>Introduction</title><p>Tissue-specific dysregulation of the glucocorticoid-generating enzyme 11&#x003b2;-hydroxysteroid dehydrogenase type 1 (11&#x003b2;-HSD1) in rodent (<xref ref-type="bibr" rid="bib28">Livingstone <italic>et al</italic>. 2000</xref>, <xref ref-type="bibr" rid="bib26">Liu <italic>et al</italic>. 2003</xref>) and human obesity (<xref ref-type="bibr" rid="bib5">Bujalska <italic>et al</italic>. 1997</xref>, <xref ref-type="bibr" rid="bib12">Fraser <italic>et al</italic>. 1999</xref>, <xref ref-type="bibr" rid="bib39">Rask <italic>et al</italic>. 2001</xref>) and the effects of 11&#x003b2;-HSD1 deficiency (<xref ref-type="bibr" rid="bib33">Morton <italic>et al</italic>. 2004</xref>) or inhibition (<xref ref-type="bibr" rid="bib1">Alberts <italic>et al</italic>. 2002</xref>, <xref ref-type="bibr" rid="bib17">Hermanowski-Vosatka <italic>et al</italic>. 2005</xref>) to protect against obesity-associated metabolic dysfunction, has supported the hypothesis that variations in glucocorticoid metabolism within target tissues play an important role in the pathophysiology of Metabolic Syndrome.</p><p>In addition to 11&#x003b2;-HSD1, glucocorticoids are metabolised by several other enzymes (<xref ref-type="fig" rid="fig1">Fig. 1</xref>). In liver, glucocorticoids are inactivated by A-ring reductases (5&#x003b1;- and 5&#x003b2;-reductases and 3&#x003b1;-HSD) and regenerated by 11&#x003b2;-HSD1 (<xref ref-type="bibr" rid="bib2">Andrew &#x00026; Walker 2002</xref>). The pattern of metabolism in adipose tissue is similar, with 5&#x003b1;-reductase 1 (5&#x003b1;R1), 3&#x003b1;-HSD and 11&#x003b2;-HSD1 being expressed (<xref ref-type="bibr" rid="bib4">Barat <italic>et al</italic>. 2007</xref>, <xref ref-type="bibr" rid="bib50">Wake <italic>et al</italic>. 2007<italic>b</italic></xref>). A-ring reductases are also dysregulated in obesity. In human obesity, whole body A-ring reduction is enhanced, as judged by urinary steroid excretion, increasing peripheral clearance of cortisol and (<xref ref-type="bibr" rid="bib3">Andrew <italic>et al</italic>. 1998</xref>, <xref ref-type="bibr" rid="bib45">Tomlinson <italic>et al</italic>. 2008</xref>) potentially inducing compensatory activation of the hypothalamic&#x02013;pituitary&#x02013;adrenal axis (<xref ref-type="bibr" rid="bib3">Andrew <italic>et al</italic>. 1998</xref>, <xref ref-type="bibr" rid="bib39">Rask <italic>et al</italic>. 2001</xref>, <xref ref-type="bibr" rid="bib40">2002</xref>). In leptin-resistant obese Zucker rats increased urinary 5&#x003b1;-reduced metabolites can be accounted for by up-regulation of expression and activities of hepatic A-ring reductases (<xref ref-type="bibr" rid="bib29">Livingstone <italic>et al</italic>. 2005</xref>). 5&#x003b1;R1 is also expressed in adipose tissue but is not dysregulated in subcutaneous (s.c.) adipose in obese humans or rats (<xref ref-type="bibr" rid="bib4">Barat <italic>et al</italic>. 2007</xref>, <xref ref-type="bibr" rid="bib50">Wake <italic>et al</italic>. 2007<italic>b</italic></xref>).</p><p>In studies of 11&#x003b2;-HSD1, up-regulation of enzyme expression in adipose tissue and down-regulation in liver has not been a universal finding in obesity. For example, in diet-induced obesity in mice and rats adipose 11&#x003b2;-HSD1 is down-regulated (<xref ref-type="bibr" rid="bib33">Morton <italic>et al</italic>. 2004</xref>, <xref ref-type="bibr" rid="bib9">Drake <italic>et al</italic>. 2005</xref>). Furthermore, leptin resistant and deficient mice have been shown by Liu <italic>et al</italic>. to have divergent changes in hepatic 11&#x003b2;-HSD1 activity, with expression and activity being decreased in leptin deficient <italic>ob/ob</italic> mice (<xref ref-type="bibr" rid="bib26">Liu <italic>et al</italic>. 2003</xref>) but paradoxically increased in leptin resistant <italic>db/db</italic> mice (<xref ref-type="bibr" rid="bib27">Liu <italic>et al</italic>. 2005</xref>). These differences may reflect the distinctions between the defects in leptin signalling in these models.</p><p>Leptin signals through several splice variants of the leptin receptor (Ob-R; <xref ref-type="bibr" rid="bib24">Lee <italic>et al</italic>. 1996</xref>). The long-form of the receptor (Ob-Rb) has an intracellular domain crucial to its signalling properties via Stat3, and is predominantly expressed in the hypothalamus, where it controls appetite regulation; this cytosolic region is truncated in the <italic>db/db</italic> mouse (<xref ref-type="bibr" rid="bib24">Lee <italic>et al</italic>. 1996</xref>, <xref ref-type="bibr" rid="bib42">Sahai <italic>et al</italic>. 2004</xref>). A short form of the receptor lacking the intracellular domain (Ob-Ra) is expressed in the liver (<xref ref-type="bibr" rid="bib18">Hoggard <italic>et al</italic>. 1997</xref>), where it can activate the inositol trisphosphate kinase cascade, thus potentially modulating insulin signalling pathways (<xref ref-type="bibr" rid="bib8">Cohen <italic>et al</italic>. 1996</xref>, <xref ref-type="bibr" rid="bib54">Zhao <italic>et al</italic>. 2000</xref>). Stimulation of Ob-Ra may occur in <italic>db/db</italic> mice, but not in <italic>ob/ob</italic> mice that lack circulating leptin. Indeed, Ob-Ra activation may be critical in the development of hepatic insulin resistance and non-alcoholic steatohepatitis (<xref ref-type="bibr" rid="bib42">Sahai <italic>et al</italic>. 2004</xref>). It is possible that activation of Ob-Ra may be responsible for leptin-induced up-regulation of 11&#x003b2;-HSD1 expression in hepatocytes (which lack Ob-Rb; <xref ref-type="bibr" rid="bib27">Liu <italic>et al</italic>. 2005</xref>), and this mechanism may mediate up-regulation of liver 11&#x003b2;-HSD1 in <italic>db/db</italic> mice. This capacity for residual leptin signalling in <italic>db/db</italic> mice is not predicted in Zucker obese rats, since the <italic>fa</italic> mutation in the leptin receptor affects the extracellular domains of both Ob-Ra and b (<xref ref-type="bibr" rid="bib7">Chua <italic>et al</italic>. 1996</xref>, <xref ref-type="bibr" rid="bib43">Da Silva <italic>et al</italic>. 1998</xref>). We therefore hypothesised that deficient leptin signalling underlies dysregulation of hepatic glucocorticoid metabolism by 11&#x003b2;-HSD1 and A-ring reductases.</p><p>The aims of the present study were to explore glucocorticoid metabolism &#x02013; not only by 11&#x003b2;-HSD1 but also by A-ring reductases &#x02013; in murine models of obesity and, by comparing findings in <italic>ob/ob</italic> and <italic>db/db</italic> mice, to dissect the potential role of Ob-Ra in mediating dysregulation of hepatic steroid metabolism in obesity.</p></sec><sec sec-type="materials|methods"><title>Materials and Methods</title><sec><title>Materials</title><p>All chemicals were obtained from Sigma unless otherwise stated. Solvents were glass distilled HPLC grade from Fisher Scientific (Loughborough, UK). Steroid standards were obtained from Steraloids (Newport, RI, USA). Radiolabelled-steroids were from GE Healthcare (Buckinghamshire, UK).</p></sec><sec><title>Animals</title><p>Male obese (Lepr<sup>DB</sup>/Lepr<sup>DB</sup> (<italic>db/db)</italic> and Lep<sup>ob</sup>/Lep<sup>ob</sup> (<italic>ob/ob)</italic>) mice and their respective lean heterozygote or wild-type littermates (<italic>Db</italic>/? and <italic>Ob/?</italic>; C57BL background; Harlan, Bicester, UK) were characterised by phenotype, maintained under controlled conditions of light (on 0700&#x02013;1900&#x0200a;h) and temperature (21&#x0200a;&#x000b0;C), and allowed free access to standard chow (Special Diet Services, Witham, UK) and drinking water. At 12 weeks of age, they were decapitated at 0800&#x02013;1100&#x0200a;h and tissues dissected and snap frozen on dry ice. All animal experiments were carried out under UK Home Office guidelines.</p></sec><sec><title>Biochemical assays</title><p>Glucose and insulin were measured by hexokinase (Thermo Electron, Melbourne, Australia) and ELISA (Crystal Chem Inc., Downers Grove, IL, USA) respectively. Hepatic triglycerides were measured spectrophotometrically (Microgenics, Passau, Germany) as previously reported (<xref ref-type="bibr" rid="bib41">Raubenheimer <italic>et al</italic>. 2006</xref>). Corticosterone was quantified in plasma by in-house RIA (<xref ref-type="bibr" rid="bib19">Holmes <italic>et al</italic>. 1995</xref>).</p></sec><sec><title>11&#x003b2;-HSD1 activity assay</title><p>11&#x003b2;-HSD1 is a reductase <italic>in vivo</italic>, converting inactive 11-dehydrocorticosterone to corticosterone. However, <italic>in vitro</italic> dehydrogenase activity predominates and measurements of reductase activity are confounded by competition with other enzymes. Therefore, to estimate 11&#x003b2;-HSD1 protein, we measured enzyme activity as conversion of corticosterone to 11-dehydrocorticosterone in the presence of an excess of cofactor NADP<sup>+</sup>. Aliquots of tissues were homogenised in Krebs Ringer buffer as previously described (<xref ref-type="bibr" rid="bib28">Livingstone <italic>et al</italic>. 2000</xref>), and protein concentrations determined colorimetrically using a Bradford kit (Bio-Rad). Standardised amounts of protein for each tissue were incubated in duplicate at 37&#x0200a;&#x000b0;C in Krebs Ringer buffer containing 0&#x000b7;2% glucose, NADP<sup>+</sup> (2&#x0200a;mmol/l), [<sup>3</sup>H]<sub>4</sub>-corticosterone (10&#x0200a;nmol/l) and unlabelled corticosterone (1&#x000b7;99&#x0200a;&#x003bc;mol/l). Protein concentrations and incubation times were optimised for each tissue to ensure first order kinetics (liver, 25&#x0200a;&#x003bc;g/ml per h; adipose tissue, 100&#x02013;200&#x0200a;&#x003bc;g/ml per h). After incubation, steroids were extracted with ethyl acetate, the organic phase evaporated under nitrogen and extracts re-solubilised in mobile phase (water:acetonitrile:methanol; 60:15:25, 1&#x000b7;5&#x0200a;ml/min). Steroids were separated by HPLC using a C18 reverse phase Symmetry column (4&#x000b7;6&#x0200a;mm, 15&#x0200a;cm, 5&#x0200a;&#x003bc;m; Waters, Elstree, UK) at 35&#x0200a;&#x000b0;C and quantified by on-line liquid scintillation counting.</p><p>Owing to the paucity of intra-abdominal adipose tissue in lean mice, omental adipose tissue was used to quantify enzyme activity, whereas mesenteric adipose was used to quantify transcript abundance.</p></sec><sec><title>5&#x003b2;-Reductase activity assay</title><p>Hepatic 5&#x003b2;-reductase (5&#x003b2;R) activity was assessed by the conversion of [<sup>3</sup>H]<sub>4</sub>-corticosterone to [<sup>3</sup>H]<sub>4</sub>-5&#x003b2;-tetrahydrocorticosterone in hepatic cytosol (<xref ref-type="bibr" rid="bib29">Livingstone <italic>et al</italic>. 2005</xref>). Enzyme velocity was measured by incubating cytosol in duplicate at 37&#x0200a;&#x000b0;C, in sodium phosphate buffer (40&#x0200a;mmol/l Na<sub>2</sub>PO<sub>4</sub>, 320&#x0200a;mmol/l sucrose, 1&#x0200a;mmol/l dithiothreitol, pH 7&#x000b7;5) containing NADPH (1&#x0200a;mmol/l), glucose-6-phosphate (5&#x0200a;mmol/l M), glucose-6-phosphate dehydrogenase (1&#x0200a;unit/ml), [<sup>3</sup>H]<sub>4</sub>-corticosterone (10&#x0200a;nmol/l) and unlabelled corticosterone (1&#x000b7;99&#x0200a;&#x003bc;mol/l; <xref ref-type="bibr" rid="bib29">Livingstone <italic>et al</italic>. 2005</xref>). Protein concentration and incubation period (0&#x000b7;5&#x0200a;mg/ml for 24&#x0200a;h) were optimised to ensure first order kinetics. Steroids were extracted with ethyl acetate, the organic phase was evaporated under nitrogen and extracts re-solubilised in mobile phase and analysed by HPLC as above.</p></sec><sec><title>Quantification of mRNA by real-time quantitative PCR</title><p>Total RNA was extracted from snap-frozen tissue samples, and 500&#x0200a;ng reverse transcribed into cDNA with random primers using the QuantiTect DNase/reverse transcription kit (Qiagen Ltd). cDNA (equivalent to 10&#x0200a;ng total RNA) was incubated in triplicate with 1&#x000d7; gene specific assay mix (Applied Biosystems, Warrington, UK) in 1&#x000d7; LightCycler480 Probes mastermix (Roche Diagnostics Ltd). PCR cycling and detection of fluorescent signal was carried out using a Roche LightCycler480. A standard curve was constructed for each primer probe set using a serial dilution of cDNA pooled from all samples. For liver and adipose, results were corrected for 18S and cyclophilin A RNA respectively, which were not different between groups. Assays used were: 11&#x003b2;-HSD1, Mm00476182_m1; 5&#x003b1;R1, Mm00614213_m1; 5&#x003b2;R, Mm00520266_m1; 18S, Hs99999901_s1 and Cyclophilin A, Mm02342430_g1.</p></sec><sec><title>Statistical analysis</title><p>Data are mean&#x000b1;<sc>s.e.m.</sc> and groups (<italic>n</italic>=10&#x02013;12 unless otherwise stated) were compared by Student's <italic>t</italic>-test.</p></sec></sec><sec><title>Results</title><p>Both <italic>db/db</italic> mice and <italic>ob/ob</italic> mice were heavier than their respective control groups at the time of cull (<xref ref-type="table" rid="tbl1">Table 1</xref>), and had increased liver weight. Both <italic>db/db</italic> and <italic>ob/ob</italic> mice had higher circulating glucose, insulin and corticosterone and hepatic triglycerides than lean controls.</p><sec><title>Hepatic glucocorticoid metabolism</title><p>Hepatic 11&#x003b2;-HSD1 activity was lower in both <italic>db/db</italic> and <italic>ob/ob</italic> mice compared with lean controls (<xref ref-type="fig" rid="fig2">Fig. 2</xref>A and B), although mRNA for 11&#x003b2;-HSD1 was not different in either model (<xref ref-type="fig" rid="fig2">Fig. 2</xref>E and F). 5&#x003b2;R activity and transcript abundance were higher in both <italic>db/db</italic> and <italic>ob/ob</italic> mice compared with their controls (<xref ref-type="fig" rid="fig2">Fig. 2</xref>C&#x02013;F). There was no difference in abundance of 5&#x003b1;R1 mRNA between lean and obese animals of either strain (<xref ref-type="fig" rid="fig2">Fig. 2</xref>E and F). Activity of 5&#x003b1;R1 was not measured due to instability of the protein (<xref ref-type="bibr" rid="bib10">Eicheler <italic>et al</italic>. 1995</xref>).</p></sec><sec><title>Glucocorticoid metabolism in adipose tissue</title><p>In <italic>db/db</italic> mice, activity of 11&#x003b2;-HSD1 was higher in retro-peritoneal and omental adipose but lower in s.c. and epidydimal adipose compared with controls (<xref ref-type="fig" rid="fig3">Fig. 3</xref>A). In <italic>ob/ob</italic> mice, 11&#x003b2;-HSD1 activity was higher in epididymal, retro-peritoneal and omental adipose but lower in s.c. adipose tissue compared with controls (<xref ref-type="fig" rid="fig3">Fig. 3</xref>B). Expression of 11&#x003b2;-HSD1 mRNA followed a similar pattern, in the main (<xref ref-type="fig" rid="fig3">Fig. 3</xref>C and D), although dysregulation of 11&#x003b2;-HSD1 mRNA was not observed in epididymal adipose tissue. Note that in mesenteric adipose tissue, limited amounts of tissue in lean mice resulted in analysis of only <italic>n</italic>=6 samples, and hence borderline statistical significance for the up-regulation of abundance of 11&#x003b2;-HSD1 mRNA in <italic>db/db</italic> mice.</p><p>Abundance of mRNA for 5&#x003b1;R1 was lower in s.c. adipose tissue from obese mice of both strains compared with their respective controls, but was not altered in mesenteric, epididymal or retro-peritoneal adipose tissue in either obese strain (<xref ref-type="fig" rid="fig3">Fig. 3</xref>E and F).</p><p>Neither 5&#x003b2;- nor 5&#x003b1;-reductase 2 mRNAs were detected in adipose tissue.</p></sec></sec><sec><title>Discussion</title><p>These studies demonstrate that mice with genetic obesity due to either defective leptin secretion (<italic>ob/ob</italic>) or sensitivity (<italic>db/db</italic>) have similar alterations in 11&#x003b2;-HSD1 and 5&#x003b2;R as Zucker obese rats (<xref ref-type="bibr" rid="bib29">Livingstone <italic>et al</italic>. 2005</xref>). This includes down-regulation of 11&#x003b2;-HSD1 in liver and up-regulation in visceral adipose tissue depots, although in obese mice 11&#x003b2;-HSD1 was lower in s.c. adipose depots. By contrast with Zucker rats (<xref ref-type="bibr" rid="bib29">Livingstone <italic>et al</italic>. 2005</xref>), however, 5&#x003b1;R1 expression was not increased in liver of obese mice and was decreased in s.c. adipose tissue. Strikingly, we did not find systematic differences between glucocorticoid metabolism in leptin deficient <italic>ob/ob</italic> mice and leptin-resistant <italic>db/db</italic> mice. This contrasts with the previous reports suggesting up-regulation of 11&#x003b2;-HSD1 in the liver of <italic>db/db</italic> mice (<xref ref-type="bibr" rid="bib27">Liu <italic>et al</italic>. 2005</xref>, <xref ref-type="bibr" rid="bib35">Nakano <italic>et al</italic>. 2007</xref>), and suggests that enhanced signalling through the short Ob-Ra splice variant does not contribute to the regulation of hepatic glucocorticoid metabolism <italic>in vivo</italic>. Previously observed effects of leptin administration <italic>in vivo</italic> to reverse changes in 11&#x003b2;-HSD1 in <italic>ob/ob</italic> mice (<xref ref-type="bibr" rid="bib26">Liu <italic>et al</italic>. 2003</xref>) may have been mediated indirectly through weight loss and reversal of the metabolic phenotype, which inevitably follow leptin replacement.</p><p>The pattern of dysregulation of glucocorticoid metabolism in obese rodents differs in some respects from that in obese humans. In human adipose tissue, up-regulation of s.c. 11&#x003b2;-HSD1 is widely reported but 5&#x003b1;R1 is not altered (<xref ref-type="bibr" rid="bib50">Wake <italic>et al</italic>. 2007<italic>b</italic></xref>) and alterations in visceral adipose 11&#x003b2;-HSD1 are inconsistent (<xref ref-type="bibr" rid="bib51">Walker &#x00026; Andrew 2006</xref>). In human liver, down-regulation of 11&#x003b2;-HSD1 and up-regulation of both 5&#x003b1;R1 and 5&#x003b2;R activity have been reported consistently (<xref ref-type="bibr" rid="bib3">Andrew <italic>et al</italic>. 1998</xref>, <xref ref-type="bibr" rid="bib12">Fraser <italic>et al</italic>. 1999</xref>, <xref ref-type="bibr" rid="bib39">Rask <italic>et al</italic>. 2001</xref>, <xref ref-type="bibr" rid="bib45">Tomlinson <italic>et al</italic>. 2008</xref>), and some of these hepatic changes are paralleled here in mice and in our studies of obese Zucker rats (<xref ref-type="bibr" rid="bib28">Livingstone <italic>et al</italic>. 2000</xref>, <xref ref-type="bibr" rid="bib29">2005</xref>, <xref ref-type="bibr" rid="bib4">Barat <italic>et al</italic>. 2007</xref>).</p><p>This species specificity provides a potential opportunity to dissect mechanisms determining dysregulation of glucocorticoid metabolism in humans using comparative studies in rodents. However, given limited knowledge of regulation of expression of A-ring reductases, the mechanism of altered A-ring reductase activity in obesity remains uncertain. 5&#x003b2;R is transiently up-regulated in rats fed a high-fat diet (<xref ref-type="bibr" rid="bib9">Drake <italic>et al</italic>. 2005</xref>), and in humans is selectively up-regulated in insulin resistance associated with fatty liver (<xref ref-type="bibr" rid="bib52">Westerbacka <italic>et al</italic>. 2003</xref>). The murine models reported here had markedly fatty liver, moreso than that induced with diet-induced obesity. However, the severity of steatosis was more marked in the <italic>ob/ob</italic> mice, whereas the activity of 5&#x003b2;-reductase was increased to a greater extent in <italic>db/db</italic> mice. The <italic>db/db</italic> mice demonstrated partial insulin deficiency, and progression towards hyperglycaemia, whereas the <italic>ob/ob</italic> mice maintained near to normal glucose concentrations, albeit with higher insulin. This perhaps implicates the elevated insulin concentrations themselves in the dysregulation of steroid metabolism. The other potent regulators of 5&#x003b2;R identified to date are androgens, which imprint permanent down-regulation of 5&#x003b2;R in liver following <italic>in </italic><italic>utero</italic> exposure (<xref ref-type="bibr" rid="bib11">Einarsson &#x00026; Gustafsson 1973</xref>, <xref ref-type="bibr" rid="bib15">Gustafsson &#x00026; Stenberg 1974</xref>, <xref ref-type="bibr" rid="bib23">Jansson <italic>et al</italic>. 1985</xref>). In addition, withdrawal of androgens increases 5&#x003b2;R (<xref ref-type="bibr" rid="bib4">Barat <italic>et al</italic>. 2007</xref>). Hence, the observed up-regulation may reflect the characteristic lowering of circulating androgens in obesity (<xref ref-type="bibr" rid="bib53">Whitaker <italic>et al</italic>. 1983</xref>, <xref ref-type="bibr" rid="bib55">Zumoff <italic>et al</italic>. 1990</xref>).</p><p>Regarding the regulation of 5&#x003b1;R1, these data suggest that the mechanism of dysregulation in human obesity is context and/or species-specific and does not operate in <italic>ob/ob</italic> or <italic>db/db</italic> mice. A caveat, however, is that protein levels or activity of 5&#x003b1;R1 might vary in the absence of changes in mRNA, but this cannot be readily tested given the instability of the hepatic 5&#x003b1;R1 protein <italic>ex vivo</italic> (<xref ref-type="bibr" rid="bib10">Eicheler <italic>et al</italic>. 1995</xref>). Previous reports in both humans and rats support the notion that up-regulation of 5&#x003b1;R1 is secondary to the development of insulin resistance/hyperinsulinaemia and is reversible on treatment (<xref ref-type="bibr" rid="bib46">Tsilchorozidou <italic>et al</italic>. 2003</xref>, <xref ref-type="bibr" rid="bib29">Livingstone <italic>et al</italic>. 2005</xref>, <xref ref-type="bibr" rid="bib45">Tomlinson <italic>et al</italic>. 2008</xref>). IGF-1 has been suggested as the principle candidate for dysregulation of hepatic 5&#x003b1;R1 (<xref ref-type="bibr" rid="bib20">Horton <italic>et al</italic>. 1993</xref>). However, both mouse strains studied exhibit profound insulin resistance and therefore this explanation may be overly simplistic. Studies of 5&#x003b1;Rs in mouse reproductive physiology have highlighted a possible redundancy between the two isozymes compared with other species (<xref ref-type="bibr" rid="bib31">Mahendroo <italic>et al</italic>. 1996</xref>, <xref ref-type="bibr" rid="bib32">2001</xref>), but this is unlikely to explain the differences in 5&#x003b1;R1 dysregulation in obese mice, since the expression of 5&#x003b1;R2 was not detected in either liver or adipose tissue.</p><p>The few reports to date examining 5&#x003b1;R1 in adipose tissue in humans and Zucker rats suggest that the abundance of transcript is not altered by obesity in s.c. depots (<xref ref-type="bibr" rid="bib4">Barat <italic>et al</italic>. 2007</xref>, <xref ref-type="bibr" rid="bib50">Wake <italic>et al</italic>. 2007<italic>b</italic></xref>). However, in both <italic>ob/ob</italic> and <italic>db/db</italic> mice, 5&#x003b1;R1 mRNA was down-regulated selectively in s.c. adipose, again highlighting the differences in regulation in this enzyme between species. In contrast to Zucker rats, in which 5&#x003b1;R1 expression was increased in omental adipose tissue (<xref ref-type="bibr" rid="bib4">Barat <italic>et al</italic>. 2007</xref>), changes in mRNA expression were not observed in the murine mesenteric depot, although the greater omental depot was not studied as a direct comparison due to a paucity of tissue in lean mice.</p><p>Regulation of 11&#x003b2;-HSD1 transcription has been studied extensively but the basis for tissues-specific dysregulation in obesity remains elusive. Species differences in regulation of 11&#x003b2;-HSD1 have been demonstrated, most recently in relation to PPAR agonists (<xref ref-type="bibr" rid="bib16">Hermanowski-Vosatka <italic>et al</italic>. 2000</xref>, <xref ref-type="bibr" rid="bib49">Wake <italic>et al</italic>. 2007<italic>a</italic></xref>). Elevated circulating glucocorticoid levels, that are much more striking in rodent than in human obesity, may contribute since 11&#x003b2;-HSD1 is a glucocorticoid-responsive gene (<xref ref-type="bibr" rid="bib30">Low <italic>et al</italic>. 1994</xref>, <xref ref-type="bibr" rid="bib21">Jamieson <italic>et al</italic>. 1995</xref>, <xref ref-type="bibr" rid="bib47">Voice <italic>et al</italic>. 1996</xref>). The striking observation in murine obesity in the present data is the down-regulation of 11&#x003b2;-HSD1 in s.c. adipose tissue. This has also been observed in diet-induced and in polygenic obesity in mice (<xref ref-type="bibr" rid="bib33">Morton <italic>et al</italic>. 2004</xref>, <xref ref-type="bibr" rid="bib34">2005</xref>). However in humans, inhibition of 11&#x003b2;-HSD1 in s.c. adipose tissue has become an attractive target for restricting glucocorticoid action, with most groups agreeing, that in humans, there is up-regulation of the enzyme in this depot (<xref ref-type="bibr" rid="bib37">Paulmyer-Lacroix <italic>et al</italic>. 2002</xref>, <xref ref-type="bibr" rid="bib25">Lindsay <italic>et al</italic>. 2003</xref>, <xref ref-type="bibr" rid="bib48">Wake <italic>et al</italic>. 2003</xref>). Of interest is the observation that changes in 11&#x003b2;-HSD1 activity in both obese models are more marked than changes in mRNA, indeed in epididymal fat mRNA was not altered. This discrepancy has been reported by ourselves (<xref ref-type="bibr" rid="bib33">Morton <italic>et al</italic>. 2004</xref>) and others (<xref ref-type="bibr" rid="bib6">Bujalska <italic>et al</italic>. 2005</xref>, <xref ref-type="bibr" rid="bib22">Jang <italic>et al</italic>. 2006</xref>) previously. The relationship between activity and abundance of transcript appears most robust in s.c. adipose in humans (<xref ref-type="bibr" rid="bib48">Wake <italic>et al</italic>. 2003</xref>, <xref ref-type="bibr" rid="bib14">Goedecke <italic>et al</italic>. 2006</xref>); discrepancies existing at other sites and observed here may reflect an additional level of control of 11&#x003b2;-HSD1 protein by post-translational modification, e.g. glycosylation (<xref ref-type="bibr" rid="bib36">Opperman <italic>et al</italic>. 1995</xref>). Another source of variation between species and depots is the mixture of cell types. 11&#x003b2;-HSD1 is expressed in macrophages as well as adipocytes (<xref ref-type="bibr" rid="bib13">Gilmour <italic>et al</italic>. 2006</xref>). There is emerging evidence that some depots, and some animal models are more susceptible to macrophage infiltration in the adipose tissue in obesity (<xref ref-type="bibr" rid="bib44">Surmi &#x00026; Hasty 2008</xref>).</p><p>In conclusion, murine obesity is characterised by some but not all of the changes in steroid metabolism that are observed in human obesity. The consequences of disrupted glucocorticoid metabolism in rodents may differ from those in humans, since rodents also exhibit substantially elevated circulating concentrations of corticosterone, contrasting with low to normal circulating cortisol in human obesity (<xref ref-type="bibr" rid="bib38">Phillips <italic>et al</italic>. 2000</xref>). Nevertheless, mice may provide useful models in which to investigate dysregulation of 5&#x003b2;R and 11&#x003b2;-HSD1 but not 5&#x003b1;R1 in liver. None of these changes differ substantially in mice with or without leptin signalling through Ob-Ra. The pattern of dysregulation of metabolism in adipose tissue is, however, subtly different between species, offering the possibility that further comparative biology studies may elucidate relevant mechanisms.</p></sec><sec><title>Declaration of interest</title><p>D E W L, S L G, G L C and R A have no conflicts of interest that could be perceived as prejudicing the impartiality of the research reported. Within the past 2 years, B R W has consulted for Astra-Zeneca, Dainippon Sumitomo, Merck, Johnson &#x00026; Johnson, Incyte, Ipsen, Roche, Vitae, Wyeth, Zydus Research Centre, received lecture fees from Abbott and Bristol Myers Squibb, and received research funding from Wyeth. B R W is an inventor on relevant patents held by University of Edinburgh.</p></sec><sec><title>Funding</title><p>This work was supported by the Wellcome Trust (060707 and VS/06/UED/A8).</p></sec><sec><title>Author contribution statement</title><p>D E W L, S L G, G L C contributed to the execution and analysis of the studies. D E W L, B R W and R A contributed to study design, data analysis and interpretation and preparation of the manuscript.</p></sec></body><back><ack><title>Acknowledgements</title><p>We are grateful to Mrs Carolynn Cairns and Mrs Rachel McDonnell for their excellent technical support.</p></ack><ref-list><title>References</title><ref id="bib1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alberts</surname><given-names>P</given-names></name><name><surname>Engblom</surname><given-names>L</given-names></name><name><surname>Edling</surname><given-names>N</given-names></name><name><surname>Forsgren</surname><given-names>M</given-names></name><name><surname>Klingstrom</surname><given-names>G</given-names></name><name><surname>Larsson</surname><given-names>C</given-names></name><name><surname>R&#x000f6;nquist-Nii</surname><given-names>Y</given-names></name><name><surname>&#x000d6;hman</surname><given-names>B</given-names></name><name><surname>Abrahms&#x000e9;n</surname><given-names>L</given-names></name></person-group><article-title>Selective inhibition of 11&#x003b2;-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice</article-title><source>Diabetologia</source><volume>45</volume><year>2002</year><fpage>1528</fpage><lpage>1532</lpage><pub-id pub-id-type="pmid">12436336</pub-id></mixed-citation></ref><ref id="bib2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrew</surname><given-names>R</given-names></name><name><surname>Walker</surname><given-names>BR</given-names></name></person-group><article-title>Glucocorticoid metabolism in health and disease</article-title><source>Recent Research Developments in Endocrinology</source><volume>3</volume><year>2002</year><fpage>425</fpage><lpage>449</lpage></mixed-citation></ref><ref id="bib3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrew</surname><given-names>R</given-names></name><name><surname>Phillips</surname><given-names>DIW</given-names></name><name><surname>Walker</surname><given-names>BR</given-names></name></person-group><article-title>Obesity and gender influence cortisol secretion and metabolism in man</article-title><source>Journal of Clinical Endocrinology and Metabolism</source><volume>83</volume><year>1998</year><fpage>1806</fpage><lpage>1809</lpage><pub-id pub-id-type="pmid">9589697</pub-id></mixed-citation></ref><ref id="bib4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barat</surname><given-names>P</given-names></name><name><surname>Livingstone</surname><given-names>DEW</given-names></name><name><surname>Elferink</surname><given-names>C</given-names></name><name><surname>MacDonnell</surname><given-names>R</given-names></name><name><surname>Walker</surname><given-names>BR</given-names></name><name><surname>Andrew</surname><given-names>R</given-names></name></person-group><article-title>Effects of gonadectomy on glucocorticoid metabolism in obese Zucker rats</article-title><source>Endocrinology</source><volume>148</volume><year>2007</year><fpage>4836</fpage><lpage>4843</lpage><pub-id pub-id-type="pmid">17628001</pub-id></mixed-citation></ref><ref id="bib5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bujalska</surname><given-names>IJ</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Stewart</surname><given-names>PM</given-names></name></person-group><article-title>Does central obesity reflect &#x02018;Cushing's disease of the omentum&#x02019;?</article-title><source>Lancet</source><volume>349</volume><year>1997</year><fpage>1210</fpage><lpage>1213</lpage><pub-id pub-id-type="pmid">9130942</pub-id></mixed-citation></ref><ref id="bib6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bujalska</surname><given-names>IJ</given-names></name><name><surname>Draper</surname><given-names>N</given-names></name><name><surname>Michailidou</surname><given-names>Z</given-names></name><name><surname>Tomlinson</surname><given-names>JW</given-names></name><name><surname>White</surname><given-names>PC</given-names></name><name><surname>Chapman</surname><given-names>KE</given-names></name><name><surname>Walker</surname><given-names>EA</given-names></name><name><surname>Stewart</surname><given-names>PM</given-names></name></person-group><article-title>Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11&#x003b2;-hydroxysteroid dehydrogenase type 1</article-title><source>Journal of Molecular Endocrinology</source><volume>34</volume><year>2005</year><fpage>675</fpage><lpage>684</lpage><pub-id pub-id-type="pmid">15956339</pub-id></mixed-citation></ref><ref id="bib7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chua</surname><given-names>SC</given-names></name><name><surname>Chung</surname><given-names>WK</given-names></name><name><surname>Wu-Peng</surname><given-names>XS</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>S-M</given-names></name><name><surname>Tartaglia</surname><given-names>L</given-names></name><name><surname>Leibel</surname><given-names>RL</given-names></name></person-group><article-title>Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor</article-title><source>Science</source><volume>271</volume><year>1996</year><fpage>994</fpage><lpage>996</lpage><pub-id pub-id-type="pmid">8584938</pub-id></mixed-citation></ref><ref id="bib8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>B</given-names></name><name><surname>Novick</surname><given-names>D</given-names></name><name><surname>Rubinstein</surname><given-names>M</given-names></name></person-group><article-title>Modulation of insulin activities by leptin</article-title><source>Science</source><volume>274</volume><year>1996</year><fpage>1185</fpage><lpage>1188</lpage><pub-id pub-id-type="pmid">8895466</pub-id></mixed-citation></ref><ref id="bib9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drake</surname><given-names>AJ</given-names></name><name><surname>Livingstone</surname><given-names>DEW</given-names></name><name><surname>Morton</surname><given-names>NM</given-names></name><name><surname>Andrew</surname><given-names>R</given-names></name><name><surname>Seckl</surname><given-names>JR</given-names></name><name><surname>Walker</surname><given-names>BR</given-names></name></person-group><article-title>Reduced adipose glucocorticoid reactivation and increased hepatic glucocorticoid clearance as an early adaptation to high fat feeding in rats</article-title><source>Endocrinology</source><volume>146</volume><year>2005</year><fpage>913</fpage><lpage>919</lpage><pub-id pub-id-type="pmid">15550507</pub-id></mixed-citation></ref><ref id="bib10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eicheler</surname><given-names>W</given-names></name><name><surname>Seitz</surname><given-names>J</given-names></name><name><surname>Steinhoff</surname><given-names>M</given-names></name><name><surname>Forssmann</surname><given-names>WG</given-names></name><name><surname>Adermann</surname><given-names>K</given-names></name><name><surname>Aumuller</surname><given-names>G</given-names></name></person-group><article-title>Distribution of rat hepatic steroid 5alpha-reductase 1 as shown by immunohistochemistry</article-title><source>Experimental and Clinical Endocrinology and Diabetes</source><volume>103</volume><year>1995</year><fpage>105</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">7553073</pub-id></mixed-citation></ref><ref id="bib11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Einarsson</surname><given-names>K</given-names></name><name><surname>Gustafsson</surname><given-names>J-A</given-names></name></person-group><article-title>Neonatal imprinting of liver microsomal hydroxylation and reduction of steroids</article-title><source>Journal of Biological Chemistry</source><volume>248</volume><year>1973</year><fpage>4987</fpage><lpage>4997</lpage><pub-id pub-id-type="pmid">4717534</pub-id></mixed-citation></ref><ref id="bib12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fraser</surname><given-names>R</given-names></name><name><surname>Ingram</surname><given-names>MC</given-names></name><name><surname>Anderson</surname><given-names>NH</given-names></name><name><surname>Morrison</surname><given-names>C</given-names></name><name><surname>Davies</surname><given-names>E</given-names></name><name><surname>Connell</surname><given-names>JMC</given-names></name></person-group><article-title>Cortisol effects on body mass, blood pressure, and cholesterol in the general population</article-title><source>American Journal of Physiology. Endocrinology and Metabolism</source><volume>33</volume><year>1999</year><fpage>1364</fpage><lpage>1368</lpage></mixed-citation></ref><ref id="bib13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilmour</surname><given-names>JS</given-names></name><name><surname>Coutinho</surname><given-names>AE</given-names></name><name><surname>Cailhier</surname><given-names>J.-F</given-names></name><name><surname>Man</surname><given-names>TY</given-names></name><name><surname>Clay</surname><given-names>M</given-names></name><name><surname>Thomas</surname><given-names>G</given-names></name><name><surname>Harris</surname><given-names>HG</given-names></name><name><surname>Mullins</surname><given-names>JJ</given-names></name><name><surname>Seckl</surname><given-names>JR</given-names></name><name><surname>Savill</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Local amplification of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 promotes macrophage phagocytosis of apoptotic leukocytes</article-title><source>Journal of Immunology</source><volume>176</volume><year>2006</year><fpage>7605</fpage><lpage>7611</lpage></mixed-citation></ref><ref id="bib14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goedecke</surname><given-names>JH</given-names></name><name><surname>Wake</surname><given-names>DJ</given-names></name><name><surname>Levitt</surname><given-names>NS</given-names></name><name><surname>Lambert</surname><given-names>EV</given-names></name><name><surname>Collins</surname><given-names>MR</given-names></name><name><surname>Morton</surname><given-names>NM</given-names></name><name><surname>Andrew</surname><given-names>R</given-names></name><name><surname>Walker</surname><given-names>BR</given-names></name><name><surname>Seckl</surname><given-names>JR</given-names></name></person-group><article-title>Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome</article-title><source>Clinical Endocrinology</source><volume>65</volume><year>2006</year><fpage>81</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">16817824</pub-id></mixed-citation></ref><ref id="bib15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gustafsson</surname><given-names>J-A</given-names></name><name><surname>Stenberg</surname><given-names>A</given-names></name></person-group><article-title>Irreversible androgenic programming at birth of microsomal and soluble rat liver steroid metabolism by neonatal testosterone</article-title><source>Journal of Biological Chemistry</source><volume>249</volume><year>1974</year><fpage>711</fpage><lpage>718</lpage><pub-id pub-id-type="pmid">4811898</pub-id></mixed-citation></ref><ref id="bib16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermanowski-Vosatka</surname><given-names>A</given-names></name><name><surname>Gerhold</surname><given-names>D</given-names></name><name><surname>Mundt</surname><given-names>SS</given-names></name><name><surname>Loving</surname><given-names>VA</given-names></name><name><surname>Lu</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Elbrecht</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Doebber</surname><given-names>T</given-names></name><name><surname>Kelly</surname><given-names>L</given-names></name><etal/></person-group><article-title>PPARalpha agonists reduce 11beta-hydroxysteroid dehydrogenase type 1 in the liver</article-title><source>Biochemical and Biophysical Research Communications</source><volume>279</volume><year>2000</year><fpage>330</fpage><lpage>336</lpage><pub-id pub-id-type="pmid">11118287</pub-id></mixed-citation></ref><ref id="bib17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermanowski-Vosatka</surname><given-names>A</given-names></name><name><surname>Balkovec</surname><given-names>JM</given-names></name><name><surname>Cheng</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>HY</given-names></name><name><surname>Hernandez</surname><given-names>M</given-names></name><name><surname>Koo</surname><given-names>GC</given-names></name><name><surname>Le Grand</surname><given-names>CB</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Metzger</surname><given-names>JM</given-names></name><name><surname>Mundt</surname><given-names>SS</given-names></name><etal/></person-group><article-title>11&#x003b2;-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice</article-title><source>Journal of Experimental Medicine</source><volume>202</volume><year>2005</year><fpage>517</fpage><lpage>527</lpage><pub-id pub-id-type="pmid">16103409</pub-id></mixed-citation></ref><ref id="bib18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoggard</surname><given-names>N</given-names></name><name><surname>Mercer</surname><given-names>JG</given-names></name><name><surname>Rayner</surname><given-names>DV</given-names></name><name><surname>Moar</surname><given-names>K</given-names></name><name><surname>Trayhurn</surname><given-names>P</given-names></name><name><surname>Williams</surname><given-names>LM</given-names></name></person-group><article-title>Localization of leptin receptor mRNA splice variants in murine peripheral tissues by RT-PCR and <italic>in situ</italic> hybridization</article-title><source>Biochemical and Biophysical Research Communications</source><volume>232</volume><year>1997</year><fpage>383</fpage><lpage>387</lpage><pub-id pub-id-type="pmid">9125186</pub-id></mixed-citation></ref><ref id="bib19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname><given-names>MC</given-names></name><name><surname>French</surname><given-names>KL</given-names></name><name><surname>Seckl</surname><given-names>JR</given-names></name></person-group><article-title>Modulation of serotonin and corticosteroid receptor gene expression in the rat hippocampus with circadian rhythm and stress</article-title><source>Molecular Brain Research</source><volume>28</volume><year>1995</year><fpage>186</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">7723617</pub-id></mixed-citation></ref><ref id="bib20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horton</surname><given-names>R</given-names></name><name><surname>Pasupuletti</surname><given-names>V</given-names></name><name><surname>Antonipillai</surname><given-names>I</given-names></name></person-group><article-title>Androgen induction of steroid 5&#x003b1;-reductase may be mediated via insulin-like growth factor-1</article-title><source>Endocrinology</source><volume>133</volume><year>1993</year><fpage>447</fpage><lpage>451</lpage><pub-id pub-id-type="pmid">8344190</pub-id></mixed-citation></ref><ref id="bib21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamieson</surname><given-names>PM</given-names></name><name><surname>Chapman</surname><given-names>KE</given-names></name><name><surname>Edwards</surname><given-names>CRW</given-names></name><name><surname>Seckl</surname><given-names>JR</given-names></name></person-group><article-title>11&#x003b2;-Hydroxysteroid dehydrogenase is an exclusive 11&#x003b2;-reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations</article-title><source>Endocrinology</source><volume>136</volume><year>1995</year><fpage>4754</fpage><lpage>4761</lpage><pub-id pub-id-type="pmid">7588203</pub-id></mixed-citation></ref><ref id="bib22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>C</given-names></name><name><surname>Obeyesekere</surname><given-names>VR</given-names></name><name><surname>Dilley</surname><given-names>RJ</given-names></name><name><surname>Alford</surname><given-names>FP</given-names></name><name><surname>Inder</surname><given-names>WJ</given-names></name></person-group><article-title>11&#x003b2;-Hydroxysteroid dehydrogenase type 1 is expressed and is biologically active in human skeletal muscle</article-title><source>Clinical Endocrinology</source><volume>65</volume><year>2006</year><fpage>800</fpage><lpage>805</lpage><pub-id pub-id-type="pmid">17121533</pub-id></mixed-citation></ref><ref id="bib23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jansson</surname><given-names>JO</given-names></name><name><surname>Ekberg</surname><given-names>S</given-names></name><name><surname>Isaksson</surname><given-names>O</given-names></name></person-group><article-title>Imprinting of growth hormone secretion, body growth, and hepatic steroid metabolism by neonatal testosterone</article-title><source>Endocrinology</source><volume>117</volume><year>1985</year><fpage>1881</fpage><lpage>1889</lpage><pub-id pub-id-type="pmid">4042968</pub-id></mixed-citation></ref><ref id="bib24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>G-H</given-names></name><name><surname>Proenca</surname><given-names>R</given-names></name><name><surname>Montez</surname><given-names>JM</given-names></name><name><surname>Carroll</surname><given-names>KM</given-names></name><name><surname>Darvishzadeh</surname><given-names>JG</given-names></name><name><surname>Lee</surname><given-names>JI</given-names></name><name><surname>Friedman</surname><given-names>JM</given-names></name></person-group><article-title>Abnormal splicing of the leptin receptor in diabetic mice</article-title><source>Nature</source><volume>379</volume><year>1996</year><fpage>632</fpage><lpage>635</lpage><pub-id pub-id-type="pmid">8628397</pub-id></mixed-citation></ref><ref id="bib25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindsay</surname><given-names>RS</given-names></name><name><surname>Tataranni</surname><given-names>A</given-names></name><name><surname>Permana</surname><given-names>P</given-names></name><name><surname>Livingstone</surname><given-names>DEW</given-names></name><name><surname>Wake</surname><given-names>DJ</given-names></name><name><surname>Walker</surname><given-names>BR</given-names></name></person-group><article-title>Subcutaneous adipose 11&#x003b2;-hydroxysteroid dehydrogenase type 1 activity and mRNA levels are associated with adiposity and insulinaemia in Pima Indians and Caucasians</article-title><source>Journal of Clinical Endocrinology and Metabolism</source><volume>88</volume><year>2003</year><fpage>2738</fpage><lpage>2744</lpage><pub-id pub-id-type="pmid">12788882</pub-id></mixed-citation></ref><ref id="bib26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Nakagawa</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Ohzeki</surname><given-names>T</given-names></name><name><surname>Friedman</surname><given-names>TC</given-names></name></person-group><article-title>Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycaemia in leptin deficient ob/ob mice</article-title><source>Diabetes</source><volume>52</volume><year>2003</year><fpage>1409</fpage><lpage>1416</lpage><pub-id pub-id-type="pmid">12765951</pub-id></mixed-citation></ref><ref id="bib27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Nakagawa</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Sakurai</surname><given-names>R</given-names></name><name><surname>Tripathi</surname><given-names>PV</given-names></name><name><surname>Lutfy</surname><given-names>K</given-names></name><name><surname>Friedman</surname><given-names>TC</given-names></name></person-group><article-title>Increased glucocorticoid receptor and 11&#x003b2;-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in <italic>db/db</italic> mice</article-title><source>Diabetes</source><volume>54</volume><year>2005</year><fpage>32</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">15616008</pub-id></mixed-citation></ref><ref id="bib28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livingstone</surname><given-names>DEW</given-names></name><name><surname>Jones</surname><given-names>GC</given-names></name><name><surname>Smith</surname><given-names>K</given-names></name><name><surname>Andrew</surname><given-names>R</given-names></name><name><surname>Kenyon</surname><given-names>CJ</given-names></name><name><surname>Walker</surname><given-names>BR</given-names></name></person-group><article-title>Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats</article-title><source>Endocrinology</source><volume>141</volume><year>2000</year><fpage>560</fpage><lpage>563</lpage><pub-id pub-id-type="pmid">10650936</pub-id></mixed-citation></ref><ref id="bib29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livingstone</surname><given-names>DEW</given-names></name><name><surname>McInnes</surname><given-names>KJ</given-names></name><name><surname>Walker</surname><given-names>BR</given-names></name><name><surname>Andrew</surname><given-names>R</given-names></name></person-group><article-title>Increased A-ring reduction of glucocorticoids in obese rats: attenuation by insulin sensitisation</article-title><source>Obesity Research</source><volume>13</volume><year>2005</year><fpage>1523</fpage><lpage>1526</lpage><pub-id pub-id-type="pmid">16222053</pub-id></mixed-citation></ref><ref id="bib30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Low</surname><given-names>SC</given-names></name><name><surname>Moisan</surname><given-names>M-P</given-names></name><name><surname>Edwards</surname><given-names>CRW</given-names></name><name><surname>Seckl</surname><given-names>JR</given-names></name></person-group><article-title>Glucocorticoids and chronic stress up-regulate 11b-hydroxysteroid dehydrogenase activity and gene expression in the hippocampus</article-title><source>Journal of Neuroendocrinology</source><volume>6</volume><year>1994</year><fpage>285</fpage><lpage>290</lpage><pub-id pub-id-type="pmid">7920594</pub-id></mixed-citation></ref><ref id="bib31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahendroo</surname><given-names>MS</given-names></name><name><surname>Cala</surname><given-names>KM</given-names></name><name><surname>Russell</surname><given-names>DW</given-names></name></person-group><article-title>5&#x003b1;-Reduced androgens play a key role in murine parturition</article-title><source>Molecular Endocrinology</source><volume>10</volume><year>1996</year><fpage>380</fpage><lpage>392</lpage><pub-id pub-id-type="pmid">8721983</pub-id></mixed-citation></ref><ref id="bib32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahendroo</surname><given-names>MS</given-names></name><name><surname>Cala</surname><given-names>KM</given-names></name><name><surname>Hess</surname><given-names>DL</given-names></name><name><surname>Russell</surname><given-names>DW</given-names></name></person-group><article-title>Unexpected virilization in male mice lacking steroid 5&#x003b1;-reductase enzymes</article-title><source>Endocrinology</source><volume>142</volume><year>2001</year><fpage>4652</fpage><lpage>4662</lpage><pub-id pub-id-type="pmid">11606430</pub-id></mixed-citation></ref><ref id="bib33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morton</surname><given-names>NM</given-names></name><name><surname>Paterson</surname><given-names>JM</given-names></name><name><surname>Masuzaki</surname><given-names>H</given-names></name><name><surname>Holmes</surname><given-names>MC</given-names></name><name><surname>Staels</surname><given-names>B</given-names></name><name><surname>Fievet</surname><given-names>C</given-names></name><name><surname>Walker</surname><given-names>BR</given-names></name><name><surname>Flier</surname><given-names>JS</given-names></name><name><surname>Mullins</surname><given-names>JJ</given-names></name><name><surname>Seckl</surname><given-names>JR</given-names></name></person-group><article-title>Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11beta-hydroxysteroid dehydrogenase type 1-deficient mice</article-title><source>Diabetes</source><volume>53</volume><year>2004</year><fpage>931</fpage><lpage>938</lpage><pub-id pub-id-type="pmid">15047607</pub-id></mixed-citation></ref><ref id="bib34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morton</surname><given-names>NM</given-names></name><name><surname>Densmore</surname><given-names>V</given-names></name><name><surname>Wamil</surname><given-names>M</given-names></name><name><surname>Ramage</surname><given-names>L</given-names></name><name><surname>Nichol</surname><given-names>K</given-names></name><name><surname>Bunger</surname><given-names>L</given-names></name><name><surname>Seckl</surname><given-names>JR</given-names></name><name><surname>Kenyon</surname><given-names>CJ</given-names></name></person-group><article-title>A polygenic model of the Metabolic Syndrome with reduced circulating and intra-adipose glucocorticoid action</article-title><source>Diabetes</source><volume>54</volume><year>2005</year><fpage>3371</fpage><lpage>3378</lpage><pub-id pub-id-type="pmid">16306351</pub-id></mixed-citation></ref><ref id="bib35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakano</surname><given-names>K</given-names></name><name><surname>Inada</surname><given-names>Y</given-names></name><name><surname>Masuzaki</surname><given-names>H</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Yasue</surname><given-names>S</given-names></name><name><surname>Ishii</surname><given-names>T</given-names></name><name><surname>Arai</surname><given-names>N</given-names></name><name><surname>Ebihara</surname><given-names>K</given-names></name><name><surname>Hosada</surname><given-names>K</given-names></name><name><surname>Maruyama</surname><given-names>K</given-names></name><etal/></person-group><article-title>Bezafibrate regulated the expression and enzyme activity of 11&#x003b2;-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes</article-title><source>American Journal of Physiology. Endocrinology and Metabolism</source><volume>292</volume><year>2007</year><fpage>E1213</fpage><lpage>E1222</lpage><pub-id pub-id-type="pmid">17190905</pub-id></mixed-citation></ref><ref id="bib36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Opperman</surname><given-names>UC</given-names></name><name><surname>Netter</surname><given-names>KJ</given-names></name><name><surname>Maser</surname><given-names>E</given-names></name></person-group><article-title>Cloning and primary structure of murine 11&#x003b2;-hydroxysteroid microsomal carbonyl reductase</article-title><source>European Journal of Biochemistry</source><volume>227</volume><year>1995</year><fpage>202</fpage><lpage>208</lpage><pub-id pub-id-type="pmid">7851387</pub-id></mixed-citation></ref><ref id="bib37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paulmyer-Lacroix</surname><given-names>O</given-names></name><name><surname>Boullu</surname><given-names>S</given-names></name><name><surname>Oliver</surname><given-names>C</given-names></name><name><surname>Alessi</surname><given-names>MC</given-names></name><name><surname>Grino</surname><given-names>M</given-names></name></person-group><article-title>Expression of the mRNA coding for 11&#x003b2;-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an <italic>in situ</italic> hybridisation study</article-title><source>Journal of Clinical Endocrinology and Metabolism</source><volume>87</volume><year>2002</year><fpage>2701</fpage><lpage>2705</lpage><pub-id pub-id-type="pmid">12050237</pub-id></mixed-citation></ref><ref id="bib38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>DIW</given-names></name><name><surname>Walker</surname><given-names>BR</given-names></name><name><surname>Reynolds</surname><given-names>RM</given-names></name><name><surname>Flanagan</surname><given-names>DEH</given-names></name><name><surname>Wood</surname><given-names>PJ</given-names></name><name><surname>Osmond</surname><given-names>C</given-names></name><name><surname>Barker</surname><given-names>DJ</given-names></name><name><surname>Whorwood</surname><given-names>CB</given-names></name></person-group><article-title>Low birthweight predicts elevated plasma cortisol concentrations in adults from three populations</article-title><source>Journal of Internal Medicine</source><volume>35</volume><year>2000</year><fpage>1301</fpage><lpage>1306</lpage></mixed-citation></ref><ref id="bib39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rask</surname><given-names>E</given-names></name><name><surname>Olsson</surname><given-names>T</given-names></name><name><surname>S&#x000f6;derberg</surname><given-names>S</given-names></name><name><surname>Andrew</surname><given-names>R</given-names></name><name><surname>Livingstone</surname><given-names>DEW</given-names></name><name><surname>Johnson</surname><given-names>O</given-names></name><name><surname>Walker</surname><given-names>BR</given-names></name></person-group><article-title>Tissue-specific dysregulation of cortisol metabolism in human obesity</article-title><source>Journal of Clinical Endocrinology and Metabolism</source><volume>86</volume><year>2001</year><fpage>1418</fpage><lpage>1421</lpage><pub-id pub-id-type="pmid">11238541</pub-id></mixed-citation></ref><ref id="bib40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rask</surname><given-names>E</given-names></name><name><surname>Walker</surname><given-names>BR</given-names></name><name><surname>S&#x000f6;derberg</surname><given-names>S</given-names></name><name><surname>Livingstone</surname><given-names>DEW</given-names></name><name><surname>Eliasson</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>O</given-names></name><name><surname>Andrew</surname><given-names>R</given-names></name><name><surname>Olsson</surname><given-names>T</given-names></name></person-group><article-title>Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11&#x003b2;-hydroxysteroid dehydrogenase type 1 activity</article-title><source>Journal of Clinical Endocrinology and Metabolism</source><volume>87</volume><year>2002</year><fpage>3330</fpage><lpage>3336</lpage><pub-id pub-id-type="pmid">12107245</pub-id></mixed-citation></ref><ref id="bib41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raubenheimer</surname><given-names>PJ</given-names></name><name><surname>Nyirenda</surname><given-names>MJ</given-names></name><name><surname>Walker</surname><given-names>BR</given-names></name></person-group><article-title>A choline-deficient diet exacerbates fatty liver but attenuates insulin resistance and glucose intolerance in mice fed a high-fat diet</article-title><source>Diabetes</source><volume>55</volume><year>2006</year><fpage>2015</fpage><lpage>2020</lpage><pub-id pub-id-type="pmid">16804070</pub-id></mixed-citation></ref><ref id="bib42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahai</surname><given-names>M</given-names></name><name><surname>Malladi</surname><given-names>P</given-names></name><name><surname>Pan</surname><given-names>X</given-names></name><name><surname>Paul</surname><given-names>R</given-names></name><name><surname>Melin-Aldana</surname><given-names>H</given-names></name><name><surname>Green</surname><given-names>RM</given-names></name><name><surname>Whittington</surname><given-names>PF</given-names></name></person-group><article-title>Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin</article-title><source>American Journal of Physiology. Gastrointestinal and Liver Physiology</source><volume>287</volume><year>2004</year><fpage>G1035</fpage><lpage>G1043</lpage><pub-id pub-id-type="pmid">15256362</pub-id></mixed-citation></ref><ref id="bib43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Da Silva</surname><given-names>BA</given-names></name><name><surname>Bjorbaek</surname><given-names>C</given-names></name><name><surname>Uotani</surname><given-names>S</given-names></name><name><surname>Flier</surname><given-names>JS</given-names></name></person-group><article-title>Functional properties of leptin receptor isoforms containing the Gln-Pro extracellular domain mutation of the fatty rat</article-title><source>Endocrinology</source><volume>139</volume><year>1998</year><fpage>3681</fpage><lpage>3690</lpage><pub-id pub-id-type="pmid">9724018</pub-id></mixed-citation></ref><ref id="bib44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Surmi</surname><given-names>BK</given-names></name><name><surname>Hasty</surname><given-names>AH</given-names></name></person-group><article-title>Macrophage infiltration into adipose tissue: initiation, propagation and remodeling</article-title><source>Future Lipidology</source><volume>3</volume><year>2008</year><fpage>545</fpage><lpage>556</lpage><pub-id pub-id-type="pmid">18978945</pub-id></mixed-citation></ref><ref id="bib45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomlinson</surname><given-names>JW</given-names></name><name><surname>Finney</surname><given-names>J</given-names></name><name><surname>Hughes</surname><given-names>BA</given-names></name><name><surname>Hughes</surname><given-names>S</given-names></name><name><surname>Stewart</surname><given-names>PM</given-names></name></person-group><article-title>Reduced glucocorticoid production rate, decreased 5&#x003b1;-reductase activity and adipose tissue insulin sensitization following weight loss</article-title><source>Diabetes</source><volume>57</volume><year>2008</year><fpage>1536</fpage><lpage>1543</lpage><pub-id pub-id-type="pmid">18340018</pub-id></mixed-citation></ref><ref id="bib46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsilchorozidou</surname><given-names>T</given-names></name><name><surname>Honour</surname><given-names>JW</given-names></name><name><surname>Conway</surname><given-names>GS</given-names></name></person-group><article-title>Altered cortisol metabolism in Polycystic Ovary Syndrome: insulin enhances 5&#x003b1;-reduction but not the elevated adrenal steroid production rates</article-title><source>Journal of Clinical Endocrinology and Metabolism</source><volume>88</volume><year>2003</year><fpage>5907</fpage><lpage>5913</lpage><pub-id pub-id-type="pmid">14671189</pub-id></mixed-citation></ref><ref id="bib47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voice</surname><given-names>MW</given-names></name><name><surname>Seckl</surname><given-names>JR</given-names></name><name><surname>Edwards</surname><given-names>CRW</given-names></name><name><surname>Chapman</surname><given-names>KE</given-names></name></person-group><article-title>11beta-Hydroxysteroid dehydrogenase type 1 expression in 2S FAZA hepatoma cells is hormonally regulated: a model system for the study of hepatic glucocorticoid metabolism</article-title><source>Biochemical Journal</source><volume>317</volume><year>1996</year><fpage>621</fpage><lpage>625</lpage><pub-id pub-id-type="pmid">8713094</pub-id></mixed-citation></ref><ref id="bib48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wake</surname><given-names>DJ</given-names></name><name><surname>Rask</surname><given-names>E</given-names></name><name><surname>Livingstone</surname><given-names>DEW</given-names></name><name><surname>Soderberg</surname><given-names>S</given-names></name><name><surname>Olsson</surname><given-names>T</given-names></name><name><surname>Walker</surname><given-names>BR</given-names></name></person-group><article-title>Local and systemic impact of transcriptional upregulation of 11&#x003b2;-hydroxysteroid dehydrogenase type 1 in human adipose tissues in obesity</article-title><source>Journal of Clinical Endocrinology and Metabolism</source><volume>88</volume><year>2003</year><fpage>3983</fpage><lpage>3988</lpage><pub-id pub-id-type="pmid">12915696</pub-id></mixed-citation></ref><ref id="bib49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wake</surname><given-names>DJ</given-names></name><name><surname>Stimson</surname><given-names>RH</given-names></name><name><surname>Tan</surname><given-names>GD</given-names></name><name><surname>Andrew</surname><given-names>R</given-names></name><name><surname>Homer</surname><given-names>NZM</given-names></name><name><surname>Karpe</surname><given-names>F</given-names></name><name><surname>Walker</surname><given-names>BR</given-names></name></person-group><article-title>Influence of peroxisome proliferator-activated receptor (PPAR) &#x003b1; and &#x003b3; agonists on 11&#x003b2;-hydroxysteroid dehydrogenase type 1 <italic>in vivo</italic> in humans</article-title><source>Journal of Clinical Endocrinology and Metabolism</source><volume>92</volume><year>2007a</year><fpage>1848</fpage><lpage>1856</lpage><pub-id pub-id-type="pmid">17327378</pub-id></mixed-citation></ref><ref id="bib50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wake</surname><given-names>DJ</given-names></name><name><surname>Strand</surname><given-names>M</given-names></name><name><surname>Rask</surname><given-names>E</given-names></name><name><surname>Westerbacka</surname><given-names>J</given-names></name><name><surname>Livingstone</surname><given-names>DEW</given-names></name><name><surname>Soderberg</surname><given-names>S</given-names></name><name><surname>Andrew</surname><given-names>R</given-names></name><name><surname>Olsson</surname><given-names>T</given-names></name><name><surname>Yki-Jarvinen</surname><given-names>H</given-names></name><name><surname>Walker</surname><given-names>BR</given-names></name></person-group><article-title>The influence of intra-adipose enzymes generating estrogens and androgens on body fat distribution in idiopathic human obesity</article-title><source>Clinical Endocrinology</source><volume>66</volume><year>2007b</year><fpage>440</fpage><lpage>446</lpage><pub-id pub-id-type="pmid">17302881</pub-id></mixed-citation></ref><ref id="bib51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>BR</given-names></name><name><surname>Andrew</surname><given-names>R</given-names></name></person-group><article-title>Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease</article-title><source>Annals of the New York Academy of Sciences</source><volume>1083</volume><year>2006</year><fpage>165</fpage><lpage>184</lpage><pub-id pub-id-type="pmid">17148739</pub-id></mixed-citation></ref><ref id="bib52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westerbacka</surname><given-names>J</given-names></name><name><surname>Yki-Jarvinen</surname><given-names>H</given-names></name><name><surname>Vehkavaara</surname><given-names>S</given-names></name><name><surname>H&#x000e4;kkinen</surname><given-names>A-M</given-names></name><name><surname>Andrew</surname><given-names>R</given-names></name><name><surname>Wake</surname><given-names>DJ</given-names></name><name><surname>Seckl</surname><given-names>JR</given-names></name><name><surname>Walker</surname><given-names>BR</given-names></name></person-group><article-title>Body fat distribution and cortisol metabolism in healthy men: enhanced 5&#x003b2;-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver</article-title><source>Journal of Clinical Endocrinology and Metabolism</source><volume>88</volume><year>2003</year><fpage>4924</fpage><lpage>4931</lpage><pub-id pub-id-type="pmid">14557475</pub-id></mixed-citation></ref><ref id="bib53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitaker</surname><given-names>EM</given-names></name><name><surname>Shaw</surname><given-names>MA</given-names></name><name><surname>Hervey</surname><given-names>GR</given-names></name></person-group><article-title>Plasma oestradiol-17beta and testosterone concentrations as possible causes of the infertility of congenitally obese Zucker rats</article-title><source>Journal of Endocrinology</source><volume>99</volume><year>1983</year><fpage>485</fpage><lpage>490</lpage><pub-id pub-id-type="pmid">6685752</pub-id></mixed-citation></ref><ref id="bib54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>AZ</given-names></name><name><surname>Shinohara</surname><given-names>MM</given-names></name><name><surname>Huang</surname><given-names>D</given-names></name><name><surname>Shimizu</surname><given-names>M</given-names></name><name><surname>Eldar-Finkelman</surname><given-names>H</given-names></name><name><surname>Krebs</surname><given-names>EG</given-names></name><name><surname>Beavo</surname><given-names>JA</given-names></name><name><surname>Bornfeldt</surname><given-names>KE</given-names></name></person-group><article-title>Leptin induces insulin-like signalling that antagonizes cAMP elevation by glucagon in hepatocytes</article-title><source>Journal of Biological Chemistry</source><volume>275</volume><year>2000</year><fpage>11348</fpage><lpage>11354</lpage><pub-id pub-id-type="pmid">10753948</pub-id></mixed-citation></ref><ref id="bib55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zumoff</surname><given-names>B</given-names></name><name><surname>Strain</surname><given-names>GW</given-names></name><name><surname>Miller</surname><given-names>LK</given-names></name><name><surname>Rosner</surname><given-names>W</given-names></name><name><surname>Senie</surname><given-names>R</given-names></name><name><surname>Seres</surname><given-names>D</given-names></name></person-group><article-title>Plasma free and nonsex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity</article-title><source>Journal of Clinical Endocrinology and Metabolism</source><volume>71</volume><year>1990</year><fpage>929</fpage><lpage>931</lpage><pub-id pub-id-type="pmid">2401718</pub-id></mixed-citation></ref></ref-list></back><floats-group><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Glucocorticoid metabolic pathways. A is 11-dehydrocorticosterone; B is corticosterone and HSD is hydroxysteroid dehydrogenase.</p></caption><graphic xlink:href="JOE090003f01"/></fig><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Hepatic glucocorticoid metabolism. 11&#x003b2;-HSD1 activity measured as velocity of formation of product following incubation of [<sup>3</sup>H]<sub>4</sub>-corticosterone with hepatic homogenate from (A) <italic>Db/?</italic> control (open) or <italic>db/db</italic> mice (light striped); (B) <italic>Ob/?</italic> control (black) or <italic>ob/ob</italic> mice (dark striped). 5&#x003b2;-Reductase activity measured as velocity of formation of product following incubation of [<sup>3</sup>H]<sub>4</sub>-corticosterone with hepatic cytosol from (C) <italic>Db/?</italic> control or <italic>db/db</italic> mice; (D) <italic>Ob/?</italic> control or <italic>ob/ob</italic> mice. Abundance of mRNAs for hepatic enzymes measured by real-time PCR (corrected for 18S as a housekeeping gene and presented as a percentage of respective control group) in (E) <italic>Db/?</italic> control or <italic>db/db</italic> mice; (F) <italic>Ob/?</italic> control mice or <italic>ob/ob</italic> mice. Data are mean&#x000b1;<sc>s.e.m.</sc>; <italic>n</italic>=10&#x02013;12/group; *<italic>P</italic>&#x0003c;0&#x000b7;05; **<italic>P</italic>&#x0003c;0&#x000b7;01.</p></caption><graphic xlink:href="JOE090003f02"/></fig><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Glucocorticoid metabolism in adipose tissues. 11&#x003b2;-HSD1 activity measured as velocity of formation of product following incubation of [<sup>3</sup>H]<sub>4</sub>-corticosterone with homogenates of adipose tissues from (A) <italic>Db/?</italic> control (open) or <italic>db/db</italic> mice (light striped); (B) <italic>Ob/?</italic> control (black) or <italic>ob/ob</italic> mice (dark striped). Abundance of mRNA for 11&#x003b2;-HSD1 in adipose tissue depots measured by real-time PCR (corrected for cyclophilin A as a housekeeping gene and presented as a percentage of respective control group) in (C) <italic>Db/?</italic> control or <italic>db/db</italic> mice; (D) <italic>Ob/?</italic> control or <italic>ob/ob</italic> mice. Abundance of mRNAs for 5&#x003b1;-R1 in adipose beds measured by real-time PCR (corrected for cyclophilin A as a housekeeping gene and presented as a percentage of respective control group) in (E) <italic>Db/?</italic> control or <italic>db/db</italic> mice; (F) <italic>Ob/?</italic> control or <italic>ob/ob</italic> mice. Subcut is s.c. adipose, Epi is epididymal, R/P is retro-peritoneal and Mes is mesenteric. Data are mean&#x000b1;<sc>s.e.m.</sc>; <italic>n</italic>=6&#x02013;12/group; *<italic>P</italic>&#x0003c;0&#x000b7;05; **<italic>P</italic>&#x0003c;0&#x000b7;01.</p></caption><graphic xlink:href="JOE090003f03"/></fig><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><p>Body and liver weights and plasma biochemistry of mice</p></caption><table frame="hsides" rules="groups"><tr><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"><bold><italic>Db/?</italic> control</bold></th><th align="left" rowspan="1" colspan="1"><bold><italic>db/db</italic></bold></th><th align="left" rowspan="1" colspan="1"><bold><italic>Ob/?</italic> control</bold></th><th align="left" rowspan="1" colspan="1"><bold><italic>ob/ob</italic></bold></th></tr><tr><td rowspan="1" colspan="1">Weight at cull (g)</td><td align="char" rowspan="1" colspan="1">25&#x000b7;0&#x000b1;0&#x000b7;54</td><td align="char" rowspan="1" colspan="1">34&#x000b7;5&#x000b1;0&#x000b7;92*</td><td align="char" rowspan="1" colspan="1">25&#x000b7;7&#x000b1;0&#x000b7;46</td><td align="char" rowspan="1" colspan="1">42&#x000b7;1&#x000b1;0&#x000b7;55<sup>&#x02020;</sup></td></tr><tr><td rowspan="1" colspan="1">Liver (g)</td><td align="char" rowspan="1" colspan="1">1&#x000b7;31&#x000b1;0&#x000b7;02</td><td align="char" rowspan="1" colspan="1">2&#x000b7;14&#x000b1;0&#x000b7;14*</td><td align="char" rowspan="1" colspan="1">1&#x000b7;41&#x000b1;0&#x000b7;08</td><td align="char" rowspan="1" colspan="1">3&#x000b7;79&#x000b1;0&#x000b7;04<sup>&#x02020;</sup></td></tr><tr><td rowspan="1" colspan="1">Glucose (mg/dl)</td><td align="char" rowspan="1" colspan="1">223&#x000b1;14</td><td align="char" rowspan="1" colspan="1">550&#x000b1;68*</td><td align="char" rowspan="1" colspan="1">207&#x000b1;109</td><td align="char" rowspan="1" colspan="1">367&#x000b1;42<sup>&#x02020;</sup></td></tr><tr><td rowspan="1" colspan="1">Insulin (pg/ml)</td><td align="char" rowspan="1" colspan="1">1&#x000b7;2&#x000b1;0&#x000b7;2</td><td align="char" rowspan="1" colspan="1">5&#x000b7;5&#x000b1;0&#x000b7;9*</td><td align="char" rowspan="1" colspan="1">0&#x000b7;5&#x000b1;0&#x000b7;1</td><td align="char" rowspan="1" colspan="1">&#x0003e;12&#x000b7;8<sup>&#x02020;</sup></td></tr><tr><td rowspan="1" colspan="1">Liver TAG (&#x003bc;mol/g)</td><td align="char" rowspan="1" colspan="1">34&#x000b7;7&#x000b1;3&#x000b7;5</td><td align="char" rowspan="1" colspan="1">728&#x000b1;178*</td><td align="char" rowspan="1" colspan="1">36&#x000b7;3&#x000b1;5&#x000b7;3</td><td align="char" rowspan="1" colspan="1">2287&#x000b1;130<sup>&#x02020;</sup></td></tr><tr><td rowspan="1" colspan="1">Corticosterone (nM)</td><td align="char" rowspan="1" colspan="1">7&#x000b7;2&#x000b1;1&#x000b7;4</td><td align="char" rowspan="1" colspan="1">60&#x000b7;3&#x000b1;19&#x000b7;5**</td><td align="char" rowspan="1" colspan="1">17&#x000b7;9&#x000b1;4&#x000b7;7</td><td align="char" rowspan="1" colspan="1">77&#x000b7;4&#x000b1;16&#x000b7;0<sup>&#x02020;</sup></td></tr></table><table-wrap-foot><fn><p>Data are mean&#x000b1;<sc>s.e.m.</sc>, compared by Student's <italic>t</italic>-test. *<italic>P</italic>&#x0003c;0&#x000b7;005, **<italic>P</italic>&#x0003c;0&#x000b7;01 for <italic>db/db</italic> mice versus <italic>Db/?</italic> control. <sup>&#x02020;</sup><italic>P</italic>&#x0003c;0&#x000b7;005 versus <italic>ob/ob</italic> mice versus <italic>Ob/? </italic>control. <italic>N</italic>=10&#x02013;13/group. NB insulin concentrations in all <italic>ob/ob</italic> mice exceeded the maximum point of the assay. TAG, triglycerides.</p></fn></table-wrap-foot></table-wrap></floats-group></article>